Healthy Clinical Trial
Official title:
The Effects of Acute Raspberry Intake on the Relationship Between Enhanced Metabolic Control and Cognitive and Psychomotor Function
The objectives of this study are:
1. Evaluate the effects of acute dietary raspberry intake on metabolic-associated
impairments in cognitive and psychomotor function in overweight/obese adults (55-70y)
following a meal challenge
2. Evaluate the effects of acute dietary raspberry on measures of vascular function.
The proposed study will be conducted in humans according to Good Clinical Practice (GCP)
guidelines. All subjects will review and sign an Informed Consent Form approved by the
Illinois Institute of Technology's Institutional Review Boards (IRB) prior to screening.
This multi-center clinical trial is a randomized, single-blind, 2-arm, placebo-controlled,
within subject cross-over trial, featuring a repeated postprandial sampling paradigm to
evaluate the effects of acute dietary red raspberry intake on cognitive function,
inflammation, insulin sensitivity / glucose handling and vascular function in
overweight/obese older adults after consuming a standardized challenge meal.
A planned sample size of 30 will be enrolled into the study. This study will require one
initial screening visit and 3 study visits. This study will take approximately 3-4 weeks per
subject to complete.
The initial screening visit will provide subject with their site-specific, IRB-approved
informed consent document prior to the start of any study related procedures. Subject
eligibility will be determined through anthropometric measurements, vital signs, fasting
blood glucose test (finger prick), and completion of a survey relate to general eating,
health, mood and exercise habits.
Eligible subjects will follow a limited polyphenolic diet throughout the duration of their
participation, although stricter guidelines will be imposed during the 3 days prior to a
study visit. Shopping lists and meal plans will be provided to subjects, along with
counseling by the investigator's study dietitians, to help subjects adhere to the limited
polyphenolic diet. The trial will initiate with a 3-day food diary to assess background
(pre-study) dietary intake followed by counseling to follow a diet relatively low in
(poly)phenolic rich-beverages/foods, which will be maintained for the duration of the
experiment. After an initial 7 day run-in period on the limited polyphenolic diet, subjects
will be randomized to 1 of 2 treatment sequences. Treatment codes will be maintained by the
principal investigator/study physician. All subjects will receive both treatments, once each
on 2 different occasions and separated by at least 1 week. Red raspberries or placebo will be
provided with a standardized meal providing 840 kcal. A low-polyphenol snack will be provided
to subjects after their final cognitive assessment.
Each visit will last ~ 9.5 hours and subjects will be required to remain at the Clinical Unit
for the duration of the visit. Blood samples will be collected at 0 (fasting) and at 0.5 h, 1
h, 2 h, 4 h, 5 h, 6 h and 7.5 h via a catheter placed on the non-dominant arm by a registered
nurse. Cognitive function will be measured at 0 (fasting), 2 h, and 6 h. FMD or NIRS will be
conducted at the CNRC or the HNRCA, respectively at 0 (fasting), and at 1 h and 5 h.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |